Click to go mobile
Select your city
Search articles from thousands of Examiners
Los Angeles Business and Finance

Business News

In this photo taken by an individual not employed by the Associated Press and obtained by the AP outside Iran shows Iranian protestors run away from tear gas fired by security in an opposition rally in Tehran, Iran, Thursday, July 9, 2009. Hundreds of young men and women chanted 'death to the dictator,' confronting police wielding batons and firing tear gas in the capital Thursday as opposition activists sought to revive street protests despite authorities' vows to 'smash' any new marches. (AP Photo) EDITORS NOTE AS A RESULT OF AN OFFICIAL IRANIAN GOVERNMENT BAN ON FOREIGN MEDIA COVERING SOME EVENTS IN IRAN, THE AP WAS PREVENTED FROM INDEPENDENT ACCESS TO THIS EVENT Thousands protest in Iran, defying crackdown vow
5 hrs ago - Thousands of protesters streamed down avenues of the capital Thursday, chanting "death to the dictator" and defying security forces who fired tear gas and charged with batons, witnesses said.
A woman who did not want to be identified holds a sign as she joins a rally calling for South Carolina Gov. Mark Sanford's resignation, Thursday, July 9, 2009, at the Statehouse in Columbia, S.C. (AP Photo/Mary Ann Chastain) State e-mails detail SC gov's Argentina plans
51 mins ago - South Carolina Gov. Mark Sanford pushed for a packed schedule but wanted to keep an evening free on the taxpayer-funded trip to Buenos Aires where he says his friendship with an Argentine woman turned physical, e-mails released Thursday show.
FILE - In this Sept. 4, 2008 file photo Sen. John Ensign, R-Nev. speaks at the Republican National Convention in St. Paul, Minn. (AP Photo/Ron Edmonds, FILE) Ensign's parents gave mistress's family $96k
5 hrs ago - Sen. John Ensign said Thursday his parents gave his mistress and her family nearly $100,000 "out of concern for the well being of longtime family friends during a difficult time," providing his first public acknowledgment that the woman received payments tied to the affair.
A wounded man lies in a hospital bed after a roadside bomb attack near a market in the Shiite enclave of Sadr City in Baghdad, Iraq, Thursday, July 9, 2009. (AP Photo/Karim Kadim) Worst violence since US pullback hits Iraq
8 hrs ago - Bombs killed nearly 60 people in Iraq on Thursday in the worst violence since U.S. combat troops withdrew from urban areas last week, and American forces released five Iranian officials suspected of aiding Shiite insurgents.
Fans of U.S. pop star Michael Jackson gather at the Tivoli Gardens in central Copenhagen, Denmark, Thursday, July 9, 2009, to commemorate the life and work of the king of pop Jackson. many gathered at Tivoli where they showed some of Michael Jackson's videos and the movie of the Live in Bucharest ? The Dangerous Tour concert. (AP Photo/POLFOTO, Jens Dige) LAPD: Michael Jackson's drug history to be probed
1 hr 4 mins ago - Detectives investigating the death of Michael Jackson are looking at his prescription drug history and trying to talk with his numerous former doctors, the Los Angeles police chief said Thursday.
FILE - In this Feb. 18, 2009 file photo, U.S. Sen. Roland Burris, D-Ill. speaks at the City Club of Chicago. A Democratic official says Burris will not run for a full Senate term in 2010. The source says Burris has begun informing Democratic officials about his decision. The official spoke anonymously because Burris had yet to announce his decision publicly. (AP Photo/M. Spencer Green, File) AP sources: Burris won't run for full Senate term
3 hrs ago - Sen. Roland Burris, whose deep ties to former Illinois Gov. Rod Blagojevich seemed to doom his Senate tenure from the start, will not run for a full Senate term in 2010. The move increases Democrats' chances of holding on to the former Senate seat of President Barack Obama.
Study: 1 in 3 breast cancer patients overtreated
5 hrs ago - One in three breast cancer patients identified in public screening programs may be treated unnecessarily, a new study says. Karsten Jorgensen and Peter Gotzsche of the Nordic Cochrane Centre in Copenhagen analyzed breast cancer trends at least seven years before and after government-run screening programs for breast cancer started in parts of Australia, Britain, Canada, Norway and Sweden.
Family members search for the graves of relatives at Burr Oak Cemetery in Alsip, Ill., Thursday, July 9, 2009, after graves were discovered dug up Wednesday and bodies dumped into unmarked mass graves in an alleged scheme to resell the plots to unsuspecting members of the public. Three men and a woman are facing felony charges after police found what they called 'startling and revolting' conditions at the historic cemetery in the south Chicago suburb. (AP Photo/M. Spencer Green) 4 Ill. cemetery workers accused in grisly plot
42 mins ago - Three gravediggers and a cemetery manager unearthed hundreds of corpses from a historic black cemetery south of Chicago, dumping some in a weeded area and double-stacking others in existing graves, in an elaborate scheme to resell the plots, authorities said Thursday. All four were charged with felonies.

BioMarin to Host Third Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, October 28 at 5:00 p.m. ET (23:00 CET)

Distributed by Press Release

NOVATO, Calif. (Map) - NOVATO, Calif., Oct. 7 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will host a conference call and webcast on Tuesday, October 28, at 5:00 p.m. ET (23:00 CET) to discuss third quarter 2008 financial results.

U.S. / Canada Dial-in Number: 800.299.9630 International Dial-in Number: 617.786.2904 Participant Code: 70952576 Replay Dial-in Number: 888.286.8010 Replay International Dial-in Number: 617.801.6888 Replay Code: 67493262

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, http://www.BMRN.com. A replay of the call will be archived on the site for one week following the call.

Your Ad Here

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and preclinical product candidates. Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include 6R-BH4 for cardiovascular indications, which is currently in Phase 2 clinical development for the treatment of peripheral arterial disease and sickle cell disease, and PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase 1 clinical development for the treatment of PKU. For additional information, please visit http://www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

BioMarin(R), Naglazyme(R) and Kuvan(R) are registered trademarks of BioMarin Pharmaceutical Inc.

Aldurazyme(R) is a registered trademark of BioMarin/Genzyme LLC. Contacts: Investors Media Eugenia Shen Susan Berg BioMarin Pharmaceutical Inc. BioMarin Pharmaceutical Inc. (415) 506-6570 (415) 506-6594

pr

Your Ad Here
  
Examiner Articles by Category
View the latest »
More from Examiner.com
Associated Press
Classifieds
Events
Examiners
News By Location
News By Topic
 Press Releases
Slideshows
Stock Quotes
Today In Photos
Examiner.com Links
Blog
Examiner in the Press
Join Examiner
Advertise
RSS Feeds
Terms of Use | Privacy Policy
Contact Us
Walden Media
AEG Worldwide | AEG Live
Foundation for a Better Life
Copyright © 2009 Clarity Digital Group LLC d/b/a Examiner.com. All Rights reserved.